Pellicer F

Language: English
References: 4
Page: 1-2
PDF size: 110.65 Kb.

Text Extraction

Enacting laws that impact everyone’s health is an obligation of the modern state. It is a highly nuanced, idealistic mandate, involving a legislative and technical path riddled with pitfalls and therefore fraught with danger. This is precisely what has happened with the legislative process to ensure legal certainty regarding the use, production, transportation, and marketing of the two forms of marijuana and its alkaloids: “medicinal” and “recreational.”
This is where the problem and what I have called the socio-legislative struggles begin. Complaints were raised about the announcement by the government, when it submitted a bill amending the General Health Act and the Federal Penal Code (Opinion of the United Commissions of Justice and Health of the Minutes with a Draft Decree issuing the Federal Act for the Regulation of Cannabis and amending and adding various provisions of the General Health Act and the Federal Penal Code, 2021) to legalize marijuana for medicinal and therapeutic uses, in addition to enabling scientific research on the latter.

REFERENCES

1. Dictamen de las Comisiones Unidas de Justicia y de Salud de la Minuta con Proyectode Decreto por el que se expide la Ley Federal para la Regulación del Cannabisy reforma y adiciona diversas disposiciones de la Ley General de Salud ydel Código Penal Federal. Gaceta Parlamentaria, no. 5736-II, Cámara deDiputados, LXIV Legislatura. 10 de marzo de 2021, (México). https://gaceta.diputados.gob.mx/PDF/64/2021/mar/20210310-II.pdf

2. Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis,M. (2019). Cannabis and the Developing Brain: Insights into Its Long-LastingEffects. The Journal of Neuroscience, 39(42), 8250-8258. https://doi.org/10.1523/jneurosci.1165-19.2019

3. Smith, A., Kaufman, F., Sandy, M. S., & Cardenas, A. (2020). Cannabis ExposureDuring Critical Windows of Development: Epigenetic and Molecular PathwaysImplicated in Neuropsychiatric Disease. Current Environmental HealthReports, 7(3), 325-342. https://doi.org/10.1007/s40572-020-00275-4

4. Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smith,D. J., Pell, J. P., Sattar, N., Paré, G., & Holmes, M. V. (2017). Cannabis use andrisk of schizophrenia: a Mendelian randomization study. Molecular Psychiatry,23(5), 1287-1292. https://doi.org/10.1038/mp.2016.252